Advertisement
Singapore markets open in 1 hour 36 minutes
  • Straits Times Index

    3,314.05
    +0.57 (+0.02%)
     
  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     
  • Dow

    39,806.77
    -196.82 (-0.49%)
     
  • Nasdaq

    16,794.88
    +108.91 (+0.65%)
     
  • Bitcoin USD

    70,697.74
    +4,446.62 (+6.71%)
     
  • CMC Crypto 200

    1,488.54
    +134.13 (+9.91%)
     
  • FTSE 100

    8,424.20
    +3.94 (+0.05%)
     
  • Gold

    2,431.80
    -6.70 (-0.27%)
     
  • Crude Oil

    79.65
    -0.15 (-0.19%)
     
  • 10-Yr Bond

    4.4370
    +0.0170 (+0.38%)
     
  • Nikkei

    39,069.68
    +282.30 (+0.73%)
     
  • Hang Seng

    19,636.22
    +82.61 (+0.42%)
     
  • FTSE Bursa Malaysia

    1,627.50
    +10.88 (+0.67%)
     
  • Jakarta Composite Index

    7,266.69
    -7,317.24 (-50.17%)
     
  • PSE Index

    6,682.78
    +64.09 (+0.97%)
     

Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)

Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)

Editor’s note: We have updated the story with Kenvue’s statement in response to the report in paragraph 7

The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson and Johnson (NYSE:JNJ) in response to the discovery of tainted batches in Nigeria.

Last week, Nigeria’s regulatory body recalled a specific batch of Benylin syrup after detecting elevated levels of diethylene glycol during routine testing, Reuters reports.

This compound, along with a related toxin, has been implicated in the deaths of over 300 children across several countries since 2022, although no direct link has been established to recent recalls.

ADVERTISEMENT

The U.N. health agency intended to issue a global medical product alert to prompt heightened vigilance among national authorities, pending confirmation of certain details.

The recalled batch of Benylin syrup originated from Johnson and Johnson in South Africa before the brand’s acquisition by Kenvue Inc (NYSE:KVUE) following a spin-off last year.

Reuters noted that Kenvue was conducting an independent assessment and collaborating with health authorities to determine appropriate measures.

In an emailed statement, Kenvue said, “Using the testing method recommended by the World Health Organization, we tested the batch of Benylin® Paediatric Syrup that was subject to the recall by NAFDAC (batch 329304). Our tests did not detect any presence of diethylene glycol (DEG) or ethylene glycol (EG) in this batch. We follow strict, and robust safety and quality processes to ensure that consumers can trust our products and stand by the safety of our Benylin range.”

“We continue to work closely with health authorities and the WHO and are engaging with NAFDAC to understand their test results, including verifying the authenticity of the sampled product, the testing methodology used, and results reported by the agency.”

In addition to Nigeria, five other African nations, including Rwanda, Kenya, Tanzania, Zimbabwe, and South Africa, have withdrawn the product from circulation, with South Africa’s regulatory body recalling another batch of the syrup.

Despite the potential risks associated with diethylene glycol consumption, no reported adverse effects have been connected with the recent incident.

Previous instances of contamination in 2022 were traced back to raw materials sourced from manufacturers in India and Indonesia.

The WHO is working closely with South African authorities and the manufacturer to investigate the source of the contamination in the Benylin pediatric syrup, including scrutinizing the origin of the raw ingredients.

Kenvue asserts that pre-manufacture testing revealed no issues with the raw materials, though the possibility of counterfeit products is considered part of ongoing investigations.

Price Action: JNJ shares are up 0.35% at $146.24 at the last check Friday.

"ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga Pro - Click here to start Your 14-Day Trial Now!

Get the latest stock analysis from Benzinga?

This article Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated) originally appeared on Benzinga.com

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.